Nanotechnology offers better utilization of these therapeutic molecules as the development of curcumin nanoparticle encapsulated in polymeric micelles could show increased accumulation of curcumin in cancer cells resulting in effective eradication of CSCs (CD44+CD24− subpopulation) both in vitro and in vivo studies in colorectal cancer studies (Wang K. et al., 2012; Li and Zhang, 2014). Here, CD24 is linked to colorectal cancer.